查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1865416

全球无激素助眠产品市场：预测至2032年－按成分类型、产品形式、通路、最终用户和地区分類的分析

Hormone Free Sleep Aids Market Forecasts to 2032 - Global Analysis By Ingredient Type, Product Form, Distribution Channel, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球无激素助眠剂市场价值将达到 100 亿美元，到 2032 年将达到 167 亿美元。

预计在预测期内，该市场将以7.6%的复合年增长率成长。无激素助眠产品是指不含荷尔蒙的补充品或配方，旨在促进安稳睡眠，同时不扰乱人体荷尔蒙平衡。与褪黑素类产品不同，这些补充剂通常依靠草药萃取物、胺基酸或矿物质，例如缬草根、镁和L-茶胺酸，来帮助放鬆身心，改善睡眠品质。这些产品旨在帮助您入睡并延长睡眠时间，而不会扰乱您的昼夜节律或导致荷尔蒙依赖。

根据美国疾病管制与预防中心 (CDC) 的数据，到 2022 年，美国各州将有 30% 至 46% 的美国睡眠不足，这项持续存在的公共卫生挑战正在推动非荷尔蒙助眠剂的使用。

睡眠障碍呈上升趋势

失眠、不宁腿症候群和睡眠呼吸中止症等睡眠障碍的日益增多，是推动无激素助眠产品市场发展的主要动力。随着人们对睡眠健康的日益关注，消费者正积极寻求非荷尔蒙类的睡眠障碍解决方案，以避免对内分泌系统造成不利影响。此外，压力水平上升、生活方式改变和萤幕使用等不利于睡眠卫生的因素也进一步加剧了这一趋势。因此，对天然无激素解决方案的需求持续成长，推动了已开发地区和新兴市场市场的蓬勃发展。

缺乏标准化剂量和法律规范不力

许多产品依赖缺乏统一临床检验的草药或营养成分，导致其疗效和安全性参差不齐。缺乏标准化通讯协定会削弱消费者信任，阻碍产品更广泛应用，尤其是在医疗保健和机构领域。此外，各地监管法规的碎片化也使产品核可和标籤标註变得复杂，为希望拓展业务或进入新市场的製造商设置了障碍。

开发经临床验证的复方製剂

透过整合镁、L-茶胺酸和缬草根等协同成分，製造商可以在维持产品不含荷尔蒙特性的同时，提升治疗效果。此类创新吸引了注重健康、寻求针对性、多功能睡眠支援的消费者。此外，临床检验和透明的标籤资讯增强了产品的可信度，并有助于其进入受监管的零售和药房管道。随着研究的不断深入，此类配方有望在竞争激烈的市场环境中推动产品差异化和优质化。

来自处方药和非处方助眠药物的竞争

处方药和非处方安眠药是治疗严重睡眠障碍的首选，因为它们通常能快速缓解症状，并有大量的临床数据支持。此外，处方药的积极行销和保险覆盖范围可能会限制消费者获得天然产品。这种竞争环境可能会阻碍市场渗透，尤其是在那些不熟悉无激素产品或对缺乏医学证据的益处持怀疑态度的使用者群体中。

新冠疫情的影响：

新冠疫情对睡眠模式产生了显着影响，导致包括无激素产品在内的助眠产品需求激增。封锁、远距办公和焦虑情绪的加剧扰乱了昼夜节律，促使消费者寻求非成瘾性治疗方法。儘管供应链中断最初影响了产品供应，但电子商务管道促进了市场的復苏和扩张。此外，疫情加速了人们对健康和预防保健的关注，使无激素助眠产品成为长期解决方案。这种消费行为的转变将持续支撑疫情后市场的持续成长。

预计在预测期内，草药/植物萃取物细分市场将占据最大的市场份额。

由于草本/植物萃取物产品广受消费者认可且​​天然，预计在预测期内将占据最大的市场份额。洋甘菊、缬草根和西番莲等成分传统上用于助眠，且被认为安全无成瘾性。胶囊、茶剂和酊剂等多种剂型进一步提高了其可及性。此外，消费者对洁净标示植物来源保健产品的兴趣日益浓厚，也推动了市场需求。该细分市场与整体健康趋势的契合度有望使其在整个预测期内保持主导地位。

预计在预测期内，软糖和咀嚼片细分市场将实现最高的复合年增长率。

由于其便利性、偏好和对年轻消费者的吸引力，预计在预测期内，软糖和咀嚼片细分市场将实现最高成长率。这些剂型简化了服用方式，无需吞服水或药片，使其成为外出携带的理想选择。此外，製造商正透过提供无糖、纯素和多种口味选择来不断创新，以扩大其消费群体。随着功能性糖果甜点在膳食补充剂领域日益普及，软糖和咀嚼片产品有望超越传统产品，推动零售和线上通路的强劲成长。

占比最大的地区：

预计在预测期内，北美将占据最大的市场份额，这主要得益于该地区对睡眠健康的高度重视、完善的健康基础设施以及良好的消费支出。该地区对预防性医疗保健的积极态度以及对自然疗法的偏好，推动了相关产品的强劲成长。此外，主要市场参与者的存在以及零售通路的广泛覆盖范围也巩固了其市场主导地位。监管部门对膳食补充剂的支持以及针对非荷尔蒙睡眠解决方案的临床研究不断增加，进一步强化了北美作为最大区域贡献者的地位。

复合年增长率最高的地区：

预计亚太地区在预测期内将实现最高的复合年增长率，这主要得益于都市化加快、生活方式相关的睡眠问题日益严重以及中产阶级在医疗保健方面支出不断增长。中国、印度和日本等国家对天然保健产品（包括助眠产品）的需求正在增加。此外，消费者对传统医学体系和草药的亲和性也推动了其接受度。随着电子商务渗透率的提高和法规结构的不断完善，该地区展现出巨大的成长潜力，使其成为成长最快的市场区隔。

免费客製化服务

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 原始研究资料
    • 二手研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 介绍
  • 司机
  • 抑制因素
  • 市场机会
  • 威胁
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 公司间的竞争

5. 全球无激素助眠产品市场（依成分类型划分）

  • 介绍
  • 草本/植物萃取物
    • 缬草根
    • 洋甘菊
    • 西番莲
    • 熏衣草
    • 睡茄
    • 其他植物
  • 胺基酸及其衍生物
    • L-茶氨酸
    • 色氨酸/5-羟色氨酸
    • GABA（γ-氨基丁酸）
    • 甘胺酸
  • 矿物质和维生素
    • 镁
    • 维生素D、B群维生素
  • 其他成分

6. 全球无激素助眠产品市场（依产品形式划分）

  • 介绍
  • 胶囊和片剂
  • 软糖/咀嚼片
  • 液体和喷雾剂
  • 粉末/条状包装
  • 茶和机能饮料

7. 全球无激素助眠产品市场（依通路划分）

  • 介绍
  • 线下分发
    • 零售药局和药局
    • 超级市场，大卖场
    • 健康保健商店
  • 线上发行
    • 电子商务平台
    • 企业自有网站（DTC）

8. 全球无激素助眠产品市场（依最终用户划分）

  • 介绍
  • 成年人（18-60岁）
  • 老年人（60岁以上）
  • 儿童（青少年）

9. 全球无激素助眠产品市场（依地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十一章 企业概况

  • Natrol LLC
  • OLLY Public Benefit Corporation
  • NOW Foods（NOW Health Group, Inc.）
  • Herbalife Nutrition Ltd.
  • Church & Dwight Co., Inc.
  • The Nature's Bounty Co.
  • GNC Holdings LLC
  • Swanson Health Products, Inc.
  • Thorne HealthTech Inc.
  • Pharmavite LLC
  • Life Extension（Life Extension Foundation）
  • Solgar, Inc.
  • Pure Encapsulations LLC
  • Jarrow Formulas, Inc.
  • Amway Corporation
  • Nestle SA
  • Blackmores Limited
  • By-Health Co., Ltd.
Product Code: SMRC32195

According to Stratistics MRC, the Global Hormone Free Sleep Aids Market is accounted for $10.0 billion in 2025 and is expected to reach $16.7 billion by 2032, growing at a CAGR of 7.6% during the forecast period. Hormone-free sleep aids are non-hormonal supplements or formulations designed to promote restful sleep without altering the body's endocrine balance. Unlike melatonin-based products, these aids typically rely on herbal extracts, amino acids, or minerals such as valerian root, magnesium, or L-theanine to support relaxation and improve sleep quality. These products aim to enhance sleep onset and duration without disrupting circadian rhythms or causing hormonal dependency.

According to the CDC, in 2022 between 30% and 46% of U.S. adults (by state) did not get sufficient sleep, a persistent public-health gap driving non-hormonal sleep aid use.

Market Dynamics:

Driver:

Rising prevalence of sleep disorders

The increasing incidence of sleep disorders such as insomnia, restless leg syndrome, and sleep apnea is a primary driver for the hormone-free sleep aids market. As awareness of sleep health grows, consumers are actively seeking non-hormonal alternatives to manage sleep disturbances without endocrine disruption. This trend is further supported by rising stress levels, lifestyle changes, and screen exposure, which contribute to poor sleep hygiene. Consequently, demand for natural, hormone-free solutions continues to expand, reinforcing market growth across both developed and emerging regions.

Restraint:

Lack of standardized dosing and regulatory oversight

Many products rely on herbal or nutritional ingredients that lack uniform clinical validation, leading to variability in efficacy and safety. This absence of standardized protocols can undermine consumer trust and restrict broader adoption, particularly in medical or institutional settings. Moreover, regulatory fragmentation across regions complicates product approvals and labeling, posing hurdles for manufacturers aiming to scale operations or enter new markets.

Opportunity:

Development of clinically-backed combination formulas

By integrating synergistic ingredients such as magnesium, L-theanine, and valerian root manufacturers can enhance therapeutic outcomes while maintaining hormone-free profiles. These innovations appeal to health-conscious consumers seeking targeted, multi-functional sleep support. Furthermore, clinical validation and transparent labeling can improve credibility and facilitate entry into regulated retail and pharmacy channels. As research advances, such formulations are expected to drive differentiation and premiumization within the competitive landscape.

Threat:

Competitions from prescription sleep medications and OTC drugs

Prescription sleep medications and OTC drugs often offer faster symptom relief and are backed by extensive clinical data, making them preferred choices for severe sleep disorders. Additionally, aggressive marketing and insurance coverage for prescription drugs can limit consumer exposure to natural options. This competitive dynamic may hinder market penetration, especially among users unfamiliar with hormone-free solutions or skeptical of their efficacy without medical endorsement.

Covid-19 Impact:

The COVID-19 pandemic significantly influenced sleep patterns, leading to heightened demand for sleep aids, including hormone-free options. Lockdowns, remote work, and increased anxiety disrupted circadian rhythms, prompting consumers to seek non-habit-forming remedies. While supply chain disruptions initially affected product availability, e-commerce channels facilitated market recovery and expansion. Moreover, the pandemic accelerated interest in wellness and preventive health, positioning hormone-free sleep aids as viable long-term solutions. This shift in consumer behavior continues to support sustained market momentum post-pandemic.

The herbal/botanical extracts segment is expected to be the largest during the forecast period

The herbal/botanical extracts segment is expected to account for the largest market share during the forecast period due to their widespread consumer acceptance and natural origin. Ingredients like chamomile, valerian root, and passionflower are traditionally used for sleep support and are perceived as safe and non-addictive. Their integration into various delivery formats capsules, teas, and tinctures further enhances accessibility. Additionally, growing interest in clean-label and plant-based wellness products reinforces demand. This segment's alignment with holistic health trends ensures its continued leadership throughout the forecast period.

The gummies and chewables segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the gummies and chewables segment is predicted to witness the highest growth rate due to their convenience, palatability, and appeal among younger demographics. These formats simplify dosing and eliminate the need for water or swallowing pills, making them ideal for on-the-go use. Moreover, manufacturers are innovating with sugar-free, vegan, and flavored variants to broaden consumer reach. As functional confectionery gains traction in the nutraceutical space, gummies and chewables are expected to outperform traditional formats, driving robust growth across retail and online channels.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by high awareness of sleep health, established wellness infrastructure, and favorable consumer spending. The region's proactive approach to preventive care and preference for natural remedies supports strong adoption. Additionally, the presence of key market players and widespread retail availability contribute to its dominance. Regulatory support for dietary supplements and increasing clinical research on non-hormonal sleep solutions further reinforce North America's position as the largest regional contributor.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by rising urbanization, lifestyle-induced sleep issues, and expanding middle-class health expenditure. Countries like China, India, and Japan are experiencing increased demand for natural wellness products, including sleep aids. Moreover, traditional medicine systems and herbal familiarity enhance consumer receptivity. As e-commerce penetration deepens and regulatory frameworks evolve, the region offers substantial growth potential, positioning Asia Pacific as the fastest-growing market segment.

Key players in the market

Some of the key players in Hormone Free Sleep Aids Market include Natrol LLC, OLLY Public Benefit Corporation, NOW Foods (NOW Health Group, Inc.), Herbalife Nutrition Ltd., Church & Dwight Co., Inc., The Nature's Bounty Co., GNC Holdings LLC, Swanson Health Products, Inc., Thorne HealthTech Inc., Pharmavite LLC, Life Extension (Life Extension Foundation), Solgar, Inc., Pure Encapsulations LLC, Jarrow Formulas, Inc., Amway Corporation, Nestle S.A., Blackmores Limited, and By-Health Co., Ltd.

Key Developments:

In September 2024, OLLY, the leading wellness brand known for innovative benefit-forward supplements, has expanded its women's line with the launch of clinically studied Mellow Menopause, designed to support menopause and provide multi-symptom management for hot flashes, night sweats, mood, fatigue and sleep*. The product recently completed its clinical trial, with very promising results that show the efficacy and innovation behind the ingredients.

In September 2023, Natrol(R), a leading sleep, mood and stress supplement brand and #1 brand of melatonin^, is launching its first-ever sleep aid supplement without melatonin, Soothing Night(R), made with effective, clinically-tested ingredients designed to reduce occasional stress and promote longer, better sleep.

Ingredients Types Covered:

  • Herbal/Botanical Extracts
  • Amino Acids and Derivatives
  • Minerals and Vitamins
  • Other Ingredients

Product Forms Covered:

  • Capsules and Tablets
  • Gummies and Chewables
  • Liquids and Sprays
  • Powders and Stick Packs
  • Teas and Functional Beverages

Distribution Channels Covered:

  • Offline Distribution
  • Online Distribution

End Users Covered:

  • Adults (18-60 Years)
  • Geriatric Population (60+ Years)
  • Pediatric (Children/Adolescents)

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Hormone Free Sleep Aids Market, By Ingredient Type

  • 5.1 Introduction
  • 5.2 Herbal/Botanical Extracts
    • 5.2.1 Valerian Root
    • 5.2.2 Chamomile
    • 5.2.3 Passionflower
    • 5.2.4 Lavender
    • 5.2.5 Ashwagandha
    • 5.2.6 Other Botanicals
  • 5.3 Amino Acids and Derivatives
    • 5.3.1 L-Theanine
    • 5.3.2 Tryptophan/5-HTP
    • 5.3.3 GABA (Gamma-Aminobutyric Acid)
    • 5.3.4 Glycine
  • 5.4 Minerals and Vitamins
    • 5.4.1 Magnesium
    • 5.4.2 Vitamin D, B-Complex
  • 5.5 Other Ingredients

6 Global Hormone Free Sleep Aids Market, By Product Form

  • 6.1 Introduction
  • 6.2 Capsules and Tablets
  • 6.3 Gummies and Chewables
  • 6.4 Liquids and Sprays
  • 6.5 Powders and Stick Packs
  • 6.6 Teas and Functional Beverages

7 Global Hormone Free Sleep Aids Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Offline Distribution
    • 7.2.1 Retail Pharmacies and Drug Stores
    • 7.2.2 Supermarkets and Hypermarkets
    • 7.2.3 Health & Wellness Stores
  • 7.3 Online Distribution
    • 7.3.1 E-commerce Platforms
    • 7.3.2 Company-Owned Websites (DTC)

8 Global Hormone Free Sleep Aids Market, By End User

  • 8.1 Introduction
  • 8.2 Adults (18-60 Years)
  • 8.3 Geriatric Population (60+ Years)
  • 8.4 Pediatric (Children/Adolescents)

9 Global Hormone Free Sleep Aids Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Natrol LLC
  • 11.2 OLLY Public Benefit Corporation
  • 11.3 NOW Foods (NOW Health Group, Inc.)
  • 11.4 Herbalife Nutrition Ltd.
  • 11.5 Church & Dwight Co., Inc.
  • 11.6 The Nature's Bounty Co.
  • 11.7 GNC Holdings LLC
  • 11.8 Swanson Health Products, Inc.
  • 11.9 Thorne HealthTech Inc.
  • 11.10 Pharmavite LLC
  • 11.11 Life Extension (Life Extension Foundation)
  • 11.12 Solgar, Inc.
  • 11.13 Pure Encapsulations LLC
  • 11.14 Jarrow Formulas, Inc.
  • 11.15 Amway Corporation
  • 11.16 Nestle S.A.
  • 11.17 Blackmores Limited
  • 11.18 By-Health Co., Ltd.

List of Tables

  • Table 1 Global Hormone Free Sleep Aids Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Hormone Free Sleep Aids Market Outlook, By Ingredient Type (2024-2032) ($MN)
  • Table 3 Global Hormone Free Sleep Aids Market Outlook, By Herbal/Botanical Extracts (2024-2032) ($MN)
  • Table 4 Global Hormone Free Sleep Aids Market Outlook, By Valerian Root (2024-2032) ($MN)
  • Table 5 Global Hormone Free Sleep Aids Market Outlook, By Chamomile (2024-2032) ($MN)
  • Table 6 Global Hormone Free Sleep Aids Market Outlook, By Passionflower (2024-2032) ($MN)
  • Table 7 Global Hormone Free Sleep Aids Market Outlook, By Lavender (2024-2032) ($MN)
  • Table 8 Global Hormone Free Sleep Aids Market Outlook, By Ashwagandha (2024-2032) ($MN)
  • Table 9 Global Hormone Free Sleep Aids Market Outlook, By Other Botanicals (2024-2032) ($MN)
  • Table 10 Global Hormone Free Sleep Aids Market Outlook, By Amino Acids and Derivatives (2024-2032) ($MN)
  • Table 11 Global Hormone Free Sleep Aids Market Outlook, By L-Theanine (2024-2032) ($MN)
  • Table 12 Global Hormone Free Sleep Aids Market Outlook, By Tryptophan/5-HTP (2024-2032) ($MN)
  • Table 13 Global Hormone Free Sleep Aids Market Outlook, By GABA (Gamma-Aminobutyric Acid) (2024-2032) ($MN)
  • Table 14 Global Hormone Free Sleep Aids Market Outlook, By Glycine (2024-2032) ($MN)
  • Table 15 Global Hormone Free Sleep Aids Market Outlook, By Minerals and Vitamins (2024-2032) ($MN)
  • Table 16 Global Hormone Free Sleep Aids Market Outlook, By Magnesium (2024-2032) ($MN)
  • Table 17 Global Hormone Free Sleep Aids Market Outlook, By Vitamin D, B-Complex (2024-2032) ($MN)
  • Table 18 Global Hormone Free Sleep Aids Market Outlook, By Other Ingredients (2024-2032) ($MN)
  • Table 19 Global Hormone Free Sleep Aids Market Outlook, By Product Form (2024-2032) ($MN)
  • Table 20 Global Hormone Free Sleep Aids Market Outlook, By Capsules and Tablets (2024-2032) ($MN)
  • Table 21 Global Hormone Free Sleep Aids Market Outlook, By Gummies and Chewables (2024-2032) ($MN)
  • Table 22 Global Hormone Free Sleep Aids Market Outlook, By Liquids and Sprays (2024-2032) ($MN)
  • Table 23 Global Hormone Free Sleep Aids Market Outlook, By Powders and Stick Packs (2024-2032) ($MN)
  • Table 24 Global Hormone Free Sleep Aids Market Outlook, By Teas and Functional Beverages (2024-2032) ($MN)
  • Table 25 Global Hormone Free Sleep Aids Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 26 Global Hormone Free Sleep Aids Market Outlook, By Offline Distribution (2024-2032) ($MN)
  • Table 27 Global Hormone Free Sleep Aids Market Outlook, By Retail Pharmacies and Drug Stores (2024-2032) ($MN)
  • Table 28 Global Hormone Free Sleep Aids Market Outlook, By Supermarkets and Hypermarkets (2024-2032) ($MN)
  • Table 29 Global Hormone Free Sleep Aids Market Outlook, By Health & Wellness Stores (2024-2032) ($MN)
  • Table 30 Global Hormone Free Sleep Aids Market Outlook, By Online Distribution (2024-2032) ($MN)
  • Table 31 Global Hormone Free Sleep Aids Market Outlook, By E-commerce Platforms (2024-2032) ($MN)
  • Table 32 Global Hormone Free Sleep Aids Market Outlook, By Company-Owned Websites (DTC) (2024-2032) ($MN)
  • Table 33 Global Hormone Free Sleep Aids Market Outlook, By End User (2024-2032) ($MN)
  • Table 34 Global Hormone Free Sleep Aids Market Outlook, By Adults (18-60 Years) (2024-2032) ($MN)
  • Table 35 Global Hormone Free Sleep Aids Market Outlook, By Geriatric Population (60+ Years) (2024-2032) ($MN)
  • Table 36 Global Hormone Free Sleep Aids Market Outlook, By Pediatric (Children/Adolescents) (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.